Rebinyn® NOW AVAILABLE!

TAKE CONTROL TO A HIGH LEVEL

Rebinyn®—reach for high factor levels in hemophilia B.

Marker icon
Clayton lives with hemophilia B and hikes

Rebinyn® NOW AVAILABLE!

TAKE CONTROL TO A HIGH LEVEL

Rebinyn®—reach for high factor levels in hemophilia B.

All images of hemophilia B patients shown are for illustrative purposes only.

Leopoldo lives with hemophilia B and is sailing

All images of hemophilia B patients shown
are for illustrative purposes only.

All images of hemophilia B patients shown are for illustrative purposes only.

WHAT IS REBINYN®?

Rebinyn® is an injectable treatment used to replace clotting Factor IX. It is used to treat and control bleeding in adults and children with hemophilia B. Your health care provider may give you Rebinyn® when you have surgery. Rebinyn® provides extended bleed protection by achieving high factor levels and keeping them higher, longer.

  • Rebinyn® is not used for routine prophylaxis or for immune tolerance therapy
  • Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) inside cells lining blood vessels in the choroid plexus, which makes the fluid that cushions the brain. The potential human implications of these animal tests are unknown

IS REBINYN® EFFECTIVE?

Rebinyn® controls bleeds when they happen. In a clinical study, Rebinyn® treated 98% of bleeds in adolescents and adults with 1-2 infusions. 95% of patients and HCPs rated bleed control as successful (defined as excellent or good) in 142 bleeding episodes.

Sticky note: 98% of bleeds treated with 1-2 infusions

aResults shown are from the on-demand arm of the adolescent/adult clinical study in previously treated patients. In this study, 15 people were treated for on-demand bleeds. In 14 people, there were a total of 143 bleeding episodes.

DOES IT FIT MY LIFESTYLE?

Rebinyn® is designed to fit your lifestyle with simplified dosing, fast infusions, and flexible storage. Rebinyn® can be infused in 1-4 minutes.

INTERESTED IN TRYING REBINYN®?

To learn more about our trial program, please call 1-844-NOVO-SEC (1-844-668-6732) to speak with a NovoSecure™ Specialist.b

bPatients who have been prescribed a Novo Nordisk hemophilia and rare bleeding disorder product for an FDA-approved indication, and who have commercial insurance may be eligible to receive a limited supply of free product. Patients who participate in any government, state, or federally funded medical or prescription benefit program, including Medicare, Medicaid, Medigap, VA, DOD, and TRICARE, including patients who participate in a managed Medicaid program or have Medicaid as secondary insurance, are not eligible to receive product support. Product is provided at no cost to the patient or the HCP, is not contingent on any product purchase, and the patient and HCP must not: (1) bill any third party for the free product, or (2) resell the free product.

HOW CAN I GET STARTED?

Getting started with Rebinyn® is easy. We’ll take you through the process step-by-step, so that you know what to expect.

Sticky note with the word

RESOURCES FOR YOU

These materials can help you stay educated on bleeding disorders.

Educational resources for people with bleeding disorders

STAY IN THE KNOW. SIGN UP TO GET THE LATEST UPDATES ON REBINYN®

STAY IN THE KNOW. SIGN UP TO GET THE LATEST UPDATES ON REBINYN®

Selected Important Safety Information

What is the most important information I need to know about Rebinyn®?

  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®.

Who should not use Rebinyn®?
Do not use Rebinyn® if you:

  • are allergic to Factor IX or any of the other ingredients of Rebinyn®.
  • are allergic to hamster proteins.
     

Indications and Usage

What is Rebinyn® Coagulation Factor IX (Recombinant), GlycoPEGylated?
Rebinyn® is an injectable medicine used to replace clotting Factor IX that is missing in patients with hemophilia B. Rebinyn® is used to treat and control bleeding in people with hemophilia B. Your healthcare provider may give you Rebinyn® when you have surgery. Rebinyn® is not used for routine prophylaxis or for immune tolerance therapy.
 

Important Safety Information

What is the most important information I need to know about Rebinyn®?

  • Do not attempt to do an infusion yourself unless you have been taught how by your healthcare provider or hemophilia treatment center. Carefully follow your healthcare provider’s instructions regarding the dose and schedule for infusing Rebinyn®.

Who should not use Rebinyn®?
Do not use Rebinyn® if you:

  • are allergic to Factor IX or any of the other ingredients of Rebinyn®.
  • are allergic to hamster proteins.

What should I tell my healthcare provider before using Rebinyn®?
Tell your healthcare provider if you:

  • have or have had any medical conditions.
  • take any medicines, including non-prescription medicines and dietary supplements.
  • are nursing, pregnant, or plan to become pregnant.
  • have been told you have inhibitors to Factor IX.

How should I use Rebinyn®?

  • Rebinyn® is given as an infusion into the vein.
  • Call your healthcare provider right away if your bleeding does not stop after taking Rebinyn®.
  • Do not stop using Rebinyn® without consulting your healthcare provider.

What are the possible side effects of Rebinyn®?

  • Common side effects include swelling, pain, rash or redness at the location of the infusion, and itching.
  • Call your healthcare provider right away or get emergency treatment right away if you get any of the following signs of an allergic reaction: hives, chest tightness, wheezing, difficulty breathing, and/or swelling of the face.
  • Tell your healthcare provider about any side effect that bothers you or that does not go away.
  • Animals given repeat doses of Rebinyn® showed Polyethylene Glycol (PEG) inside cells lining blood vessels in the choroid plexus, which makes the fluid that cushions the brain. The potential human implications of these animal tests are unknown.
     

Please click here for Prescribing Information.

Rebinyn® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.